KCNA3 and type 2 diabetes mellitus: However, in recent years, the evidence has demonstrated that blockage or modulation of other potassium channel types such as Kv1.3, Kv1.4, Kv1.7 Kv2.1, Kv2.2 and the BK channel could be an attractive target for the management of T2D [39,181,182,183,184,190].